Viable circulating tumour cell detection using multiplex RNA in situ hybridisation predicts progression-free survival in metastatic breast cancer patients.
about
The Significance of Epithelial-to-Mesenchymal Transition for Circulating Tumor CellsCirculating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal compositionMicrofluidic, marker-free isolation of circulating tumor cells from blood samplesCTC enumeration and characterization: moving toward personalized medicine.Application of circulating tumor cells scope technique on circulating tumor cell researchA cell transportation solution that preserves live circulating tumor cells in patient blood samples.Technical Insights into Highly Sensitive Isolation and Molecular Characterization of Fixed and Live Circulating Tumor Cells for Early Detection of Tumor Invasion.Bone marrow micrometastases in early breast cancer-30-year outcome.Breast cancer as a systemic disease: a view of metastasisMultiparameter Evaluation of the Heterogeneity of Circulating Tumor Cells Using Integrated RNA In Situ Hybridization and Immunocytochemical Analysis.Enrichment, detection and clinical significance of circulating tumor cells.Multispectral imaging: a review of its technical aspects and applications in anatomic pathology.Isolation and enrichment of circulating biomarkers for cancer screening, detection, and diagnostics.Circulating and disseminated tumor cells: harbingers or initiators of metastasis?Translating colorectal cancer genetics into clinically useful biomarkers.Adeno-associated virus-mediated expression of recombinant CBD-HepII polypeptide of human fibronectin inhibits metastasis of breast cancer.RNAscope for in situ detection of transcriptionally active human papillomavirus in head and neck squamous cell carcinoma.Circulating long noncoding RNA GAS5 levels are correlated to prevalence of type 2 diabetes mellitus.Expansion of patient-derived circulating tumor cells from liquid biopsies using a CTC microfluidic culture device.Associations between the Epithelial-Mesenchymal Transition Phenotypes of Circulating Tumor Cells and the Clinicopathological Features of Patients with Colorectal Cancer.Aneuploid CTC and CEC.Perspective on Cancer Therapeutics Utilizing Analysis of Circulating Tumor Cells.Disseminated tumour cells in the bone marrow in early breast cancer: morphological categories of immunocytochemically positive cells have different impact on clinical outcome.Clinical application of circulating tumor cells in breast cancer
P2860
Q26741223-5F4DE402-BDDC-4E81-8556-781E7EDDB9D6Q29615853-7C5EA578-92B0-4DA9-B152-425C9D3E25B8Q34263808-7ED3E4F9-656B-474A-9B29-C4C3F92853F2Q34577724-CD7A3F44-5C59-4D43-A4E5-5AE9DA3F606CQ35673870-A7784A89-AD8A-48D7-AB44-38BF6E660A34Q36009934-1BA0BF60-E8C3-4925-A241-921254688272Q36242936-0A67382B-31B4-4165-8567-17B1A182A6E2Q36547904-36E6F6F9-B836-457C-B68D-359670ABA368Q37011741-E3D1BC36-7F8F-4042-90CC-1B5FD7B1E7E8Q37398787-A22A2271-B427-4E42-A3BA-3DBD60F55FD8Q38102590-1A6AE1C5-D1E4-4D9A-8806-E4DF6A1DF278Q38152999-C0FCA0CF-F47F-4AE8-AD0D-7D150A722EBFQ38640437-E7965720-4538-4077-B7C5-DF0E7DE91E48Q38770774-F3222356-415B-47BC-BC70-DEDD838F6CBAQ38779895-3C37F88F-B90F-4FA8-9AE5-E2E222DCA528Q39052266-0DCD2804-1620-4200-8419-389DA549B9CCQ41894280-94C893B0-E276-4465-8EA9-259913708554Q42050374-A57FF538-EEB6-4A8C-91E8-F398DA73B373Q47273146-61148801-63D7-41C6-A5A9-3FB9AC0FC88BQ49721184-E8AECD47-5E48-4211-8F8C-2977A1D52B86Q52579590-590329DD-CD12-468D-ACA4-809C2F2527F6Q52594191-82AFF8B2-69E6-49DE-9658-6F1A553AD499Q54446497-D7C3BB22-23D4-4C76-B27B-EEC2CC94A77DQ57129057-A9915897-5449-48EA-A803-97DDCF478DA9
P2860
Viable circulating tumour cell detection using multiplex RNA in situ hybridisation predicts progression-free survival in metastatic breast cancer patients.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Viable circulating tumour cell ...... static breast cancer patients.
@ast
Viable circulating tumour cell ...... static breast cancer patients.
@en
type
label
Viable circulating tumour cell ...... static breast cancer patients.
@ast
Viable circulating tumour cell ...... static breast cancer patients.
@en
prefLabel
Viable circulating tumour cell ...... static breast cancer patients.
@ast
Viable circulating tumour cell ...... static breast cancer patients.
@en
P2093
P2860
P356
P1476
Viable circulating tumour cell ...... static breast cancer patients.
@en
P2093
A Zebrowski
R C Coombes
P2860
P2888
P304
P356
10.1038/BJC.2012.137
P407
P577
2012-04-26T00:00:00Z